naproxen has been researched along with lipoxin a4 in 1 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (lipoxin a4) | Trials (lipoxin a4) | Recent Studies (post-2010) (lipoxin a4) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 833 | 17 | 398 |
| Protein | Taxonomy | naproxen (IC50) | lipoxin a4 (IC50) |
|---|---|---|---|
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.0001 | |
| N-formyl peptide receptor 2 | Homo sapiens (human) | 0.0119 | |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.0001 | |
| Transcription factor p65 | Homo sapiens (human) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbasinazari, M; Abdi, S; Ahmadpour, F; Dabir, S; Fatehi, S; Hatami, B; Mohammad Alizadeh, AH; Nematollahi, A; Pourhoseingholi, MA | 1 |
1 trial(s) available for naproxen and lipoxin a4
| Article | Year |
|---|---|
Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
Topics: Administration, Rectal; Adult; Aged; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cholangiopancreatography, Endoscopic Retrograde; Diclofenac; Double-Blind Method; Eicosapentaenoic Acid; Female; Humans; Incidence; Indomethacin; Iran; Lipase; Lipoxins; Male; Middle Aged; Naproxen; Pancreatitis; Risk Factors; Time Factors; Treatment Outcome | 2017 |